STEMTECH CORP - STEK STOCK NEWS

Stemtech Corporation (OTCQB: STEK), a leader in nutraceuticals, has announced its sponsorship of the ADVENT EXPO. This event aims to connect millions of viewers globally in a virtual metaverse setting, promoting Stemtech's anti-aging and plant-based stem cell nutrition products. President John W. Meyer emphasized the exposure opportunities provided by the Expo, which combines health and financial aspects for potential consumers. Stemtech's products, which are patented and all-natural, are produced under stringent manufacturing practices.

Stemtech Corporation (OTCQB: STEK) announced the trademark registration of OraStem®, its all-natural toothpaste, in Mexico. This registration signifies the company's commitment to protecting its intellectual property, benefiting its Independent Business Partners and customers. OraStem boasts 14 natural ingredients, providing anti-oxidative, anti-microbial protection, and supports oral health at a cellular level. The product's efficacy is backed by numerous peer-reviewed studies. Additionally, a new travel size of OraStem will launch soon, enhancing product accessibility.

Stemtech Corporation (OTCQB: STEK), a Florida-based nutraceutical company, announced the adoption of VERB's interactive video-based sales tools to enhance customer engagement and increase sales conversion rates. The platform includes verbCRM and verbLIVE, facilitating direct sales efforts by Independent Business Partners (IBPs). Stemtech, known for its patent-protected stem cell nutrition products, aims to empower its IBPs with advanced digital tools, leveraging social media for customer acquisition. This collaboration is expected to boost marketing effectiveness and sales performance.

Stemtech Corporation (OTCQB:STEK) announced the appointment of Izzy Matos as Founding Independent Business Partner. Matos, a key figure since the company's inception in 2005, previously developed the compensation plan and built a personal network of over 70,000 individuals. A graduate of the Network Marketing Hall of Fame, he aims to leverage this new role to enhance Stemtech's growth. The company, known for its patented stem cell nutrition products, has a strong history of recognition, having appeared on the Inc. 5000 Fastest-Growing Companies list multiple times.

Stemtech Corporation responds to a stock promotion notice received from OTC Markets. The promotion was based on the past history of one of their directors. The company denies any knowledge or involvement with the promotion. The statements regarding potential share price appreciation are baseless. The company's CEO's business accomplishments mentioned in the promotion are accurate. The increased trading activity on July 8th may have been influenced by the promotion. The company clarifies its debt information and discloses several convertible notes.

Stemtech Corporation (OTCQB:STEK) reported a 38% increase in independent business partner recruitment from April 1, 2022, to June 20, 2022, compared to the same period last year. This growth has positioned the company at 93rd in the Business For Home Momentum Ranks, improving by 174 places. Stemtech specializes in patent-protected nutraceutical products that enhance adult stem cell function. The company aims to expand further in the direct sales market, which represents $192 billion in annual sales.

Stemtech Corporation (OTCQB:STEK) announced that its Chairman and CEO, Charles Arnold, received the Global Eagles Business Leader of the Year award in Fort Lauderdale, Florida. This accolade recognizes Arnold's leadership in the nutraceutical sector and his contributions to international development. Stemtech, a pioneer in stem cell nutrition, specializes in patented products that enhance the release and migration of adult stem cells. The company aims to maintain growth and innovation while adhering to strict manufacturing standards.

Stemtech Corporation (OTCQB:STEK) announced Ana Groenewold's achievement as Chairman's Club Director, highlighting a successful sales and recruitment period in May 2022. President John W. Meyer praised Ana's dedication, noting it aligns with their GLD RSH 90-Day Promotion, which saw record-breaking performance this May. Stemtech specializes in patent-protected stem cell nutrition products, manufactured under Good Manufacturing Practices. Established in 2018, the company has a rich history of growth, previously recognized on the Inc. 5000 list. For more details, visit www.stemtech.com.

Stemtech Corporation (OTCQB:STEK) has officially uplisted to the OTCQB® Venture Market. This milestone is expected to enhance visibility with high-quality investors and emphasizes the company’s commitment to financial transparency. The uplisting follows a notable rise in Stemtech's ranking on the Business For Home Momentum Rank list, where it jumped to 98th from 159th among direct selling companies, reflecting significant growth and online visibility. This achievement highlights Stemtech's ongoing efforts to progress in the nutraceutical market.